News and Announcements
Prescient Featured on Bloomberg’s – The Redchip Money Report
- Published March 02, 2016 2:48PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
2nd March 2016, ASX Announcement
The new CEO of clinical-stage oncology company Prescient Therapeutics Ltd (ASX: PTX), Steven Yatomi-Clarke, will appear on Bloomberg Network’s The Red Chip Money Report later this week. Mr Yatomi-Clarke’s interview with host Dave Gentry will air on Sunday, March 6, at 3.30 p.m. HKT on Bloomberg Asia, and 5.30 p.m. AET on Bloomberg Australia.
The interview segment can be previewed online www.redchip.com/media/1405/prescient-therapeutics-novel-treatments-for-a-range-of-cancers
To view the full announcement, please click here.